CLINICAL_TRIALS
trial_result
· 2021-01-08
Clinical Trial Update: Use of ACTIMMUNE in Patients With ADO2 [Phase 2]
Summary
Phase 2 trial update evaluating ACTIMMUNE in patients with Autosomal Dominant Osteopetrosis Type 2 has completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indiana University | Conditions: Autosomal Dominant Osteopetrosis Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2021-01-08